NASDAQ:BLRX

Biolinerx Stock Predictions

Healthcare > Biotechnology

Buy BLRX

*Your capital is at risk

$3.28

-0.110 (-3.24%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BLRX Prediction Chart

BLRX Predictions History

Latest community submissions for BLRX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Oct 3, 2018	$1.17 -99.85%	$1.34	X	87.30%	0
paoooolo @paoooolo.2570	Jun 15, 2018	$1.00 -99.83%	$1.01	V	99.00%	1
JS Pro	Jun 15, 2018	$0.95 -99.84%	$1.01	V	94.10%	0
JS Pro	Jul 21, 2017	$0.96 -99.83%	$0.96	V	99.90%	10
PumpTheseNumbers Pro	Sep 26, 2016	$1.21 -99.84%	$1.23	V	98.40%	0
JS Pro	Sep 26, 2016	$1.23 -99.83%	$1.23	V	100.00%	10
Stockdum Senior	Aug 2, 2016	$0.770 -99.83%	$0.760	V	98.70%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BLRX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BIOLINERX LTD.

BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by